Insider Transactions in Q1 2024 at Molina Healthcare, Inc. (MOH)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2024
|
Debra Bacon EVP, Medicaid |
SELL
Payment of exercise price or tax liability
|
Direct |
170
-2.48%
|
$65,790
$387.21 P/Share
|
|
Mar 01
2024
|
Debra Bacon EVP, Medicaid |
BUY
Grant, award, or other acquisition
|
Direct |
2,273
+24.93%
|
$879,651
$387.21 P/Share
|
|
Mar 01
2024
|
James Woys Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,122
+10.92%
|
$6,239,214
$387.21 P/Share
|
|
Mar 01
2024
|
James Woys Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,938
-4.66%
|
$2,298,006
$387.21 P/Share
|
|
Mar 01
2024
|
Jeff D. Barlow Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,779
+8.74%
|
$5,719,473
$387.21 P/Share
|
|
Mar 01
2024
|
Jeff D. Barlow Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
8,338
-5.58%
|
$3,226,806
$387.21 P/Share
|
|
Mar 01
2024
|
Joseph M Zubretsky President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
85,579
+9.74%
|
$33,119,073
$387.21 P/Share
|
|
Mar 01
2024
|
Joseph M Zubretsky President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
59,443
-7.88%
|
$23,004,441
$387.21 P/Share
|
|
Mar 01
2024
|
Mark Lowell Keim Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,228
+16.59%
|
$8,215,236
$387.16 P/Share
|
|
Mar 01
2024
|
Mark Lowell Keim Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,165
-10.07%
|
$3,933,855
$387.21 P/Share
|
|
Mar 01
2024
|
Maurice Hebert Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,304
+6.95%
|
$891,648
$387.18 P/Share
|
|
Mar 01
2024
|
Maurice Hebert Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
966
-4.92%
|
$373,842
$387.21 P/Share
|
|
Feb 20
2024
|
Richard M Schapiro Director |
SELL
Open market or private sale
|
Direct |
1,000
-2.1%
|
$401,000
$401.61 P/Share
|
|
Feb 15
2024
|
Dale B Wolf Director |
SELL
Open market or private sale
|
Direct |
1,500
-9.16%
|
$597,000
$398.38 P/Share
|
|
Feb 15
2024
|
Steven J Orlando Director |
SELL
Open market or private sale
|
Indirect |
750
-3.86%
|
$299,250
$399.12 P/Share
|
|
Feb 14
2024
|
Debra Bacon EVP, Medicaid |
SELL
Open market or private sale
|
Direct |
500
-9.86%
|
$198,000
$396.22 P/Share
|
|
Feb 12
2024
|
Richard M Schapiro Director |
SELL
Open market or private sale
|
Direct |
711
-2.77%
|
$273,024
$384.25 P/Share
|
|
Feb 12
2024
|
Mark Lowell Keim Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,000
-5.54%
|
$5,790,000
$386.29 P/Share
|
|
Jan 01
2024
|
Richard C Zoretic Director |
BUY
Grant, award, or other acquisition
|
Indirect |
152
+2.35%
|
$54,872
$361.31 P/Share
|
|
Jan 01
2024
|
Stephen H Lockhart Director |
BUY
Grant, award, or other acquisition
|
Direct |
152
+6.7%
|
$54,872
$361.31 P/Share
|
|
Jan 01
2024
|
Steven J Orlando Director |
BUY
Grant, award, or other acquisition
|
Indirect |
152
+0.78%
|
$54,872
$361.31 P/Share
|
|
Jan 01
2024
|
Ronna Romney Director |
BUY
Grant, award, or other acquisition
|
Indirect |
152
+0.88%
|
$54,872
$361.31 P/Share
|
|
Jan 01
2024
|
Richard M Schapiro Director |
BUY
Grant, award, or other acquisition
|
Direct |
152
+1.16%
|
$54,872
$361.31 P/Share
|
|
Jan 01
2024
|
Dale B Wolf Director |
BUY
Grant, award, or other acquisition
|
Direct |
152
+0.92%
|
$54,872
$361.31 P/Share
|
|
Jan 01
2024
|
Barbara L Brasier Director |
BUY
Grant, award, or other acquisition
|
Direct |
152
+4.1%
|
$54,872
$361.31 P/Share
|
|
Jan 01
2024
|
Daniel Cooperman Director |
BUY
Grant, award, or other acquisition
|
Direct |
152
+2.62%
|
$54,872
$361.31 P/Share
|